Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment.
Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment.
复制标题
通过完善的贝叶斯框架对多发性硬化症中的风险基因进行优先排序,然后进行组织特异性和细胞类型特征评估。
DOI:
10.1186/s12864-022-08580-y
复制
发表时间:
2022-05-11
期刊:
影响因子:
4.4
通讯作者:
中科院分区:
文献类型:
--
作者:
Multiple sclerosis (MS) is a debilitating immune-mediated disease of the central nervous system that affects over 2 million people worldwide, resulting in a heavy burden to families and entire communities. Understanding the genetic basis underlying MS could help decipher the pathogenesis and shed light on MS treatment. We refined a recently developed Bayesian framework, Integrative Risk Gene Selector (iRIGS), to prioritize risk genes associated with MS by integrating the summary statistics from the largest GWAS to date (n = 115,803), various genomic features, and gene–gene closeness. We identified 163 MS-associated prioritized risk genes (MS-PRGenes) through the Bayesian framework. We replicated 35 MS-PRGenes through two-sample Mendelian randomization (2SMR) approach by integrating data from GWAS and Genotype-Tissue Expression (GTEx) expression quantitative trait loci (eQTL) of 19 tissues. We demonstrated that MS-PRGenes had more substantial deleterious effects and disease risk. Moreover, single-cell enrichment analysis indicated MS-PRGenes were more enriched in activated macrophages and microglia macrophages than non-activated ones in control samples. Biological and drug enrichment analyses highlighted inflammatory signaling pathways. In summary, we predicted and validated a high-confidence MS risk gene set from diverse genomic, epigenomic, eQTL, single-cell, and drug data. The MS-PRGenes could further serve as a benchmark of MS GWAS risk genes for future validation or genetic studies. The online version contains supplementary material available at 10.1186/s12864-022-08580-y.
登录
查看更多内容
影响因子:
64.8
作者:
GTEx Consortium;Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group;Statistical Methods groups—Analysis Working Group;Enhancing GTEx (eGTEx) groups;NIH Common Fund;NIH/NCI;NIH/NHGRI;NIH/NIMH;NIH/NIDA;Biospecimen Collection Source Site—NDRI;Biospecimen Collection Source Site—RPCI;Biospecimen Core Resource—VARI;Brain Bank Repository—University of Miami Brain Endowment Bank;Leidos Biomedical—Project Management;ELSI Study;Genome Browser Data Integration &Visualization—EBI;Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz;Lead analysts:;Laboratory, Data Analysis &Coordinating Center (LDACC):;NIH program management:;Biospecimen collection:;Pathology:;eQTL manuscript working group:;Battle A;Brown CD;Engelhardt BE;Montgomery SB
通讯作者:
Montgomery SB
影响因子:
30.8
作者:
Fulco, Charles P.;Nasser, Joseph;Engreitz, Jesse M.
通讯作者:
Engreitz, Jesse M.
影响因子:
3.4
作者:
Garcia, Catherine R.;Jayswal, Rani;Villano, John L.
通讯作者:
Villano, John L.
影响因子:
3.7
作者:
Dai, Yulin;Pei, Guangsheng;Jia, Peilin
通讯作者:
Jia, Peilin
影响因子:
3.6
作者:
Abel AM;Schuldt KM;Rajasekaran K;Hwang D;Riese MJ;Rao S;Thakar MS;Malarkannan S
通讯作者:
Malarkannan S